New inhaled insulin combo aims to simplify diabetes care for teens

NCT ID NCT07224321

Recruiting now Disease control Sponsor: Mannkind Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study tests a new approach for teens (ages 10-17) recently diagnosed with type 1 diabetes. They will use an inhaled insulin called Afrezza along with a long-acting injected insulin. The goal is to see if this combination helps keep blood sugar in a healthy range and is safe and satisfying for patients and families. The main part lasts 13 weeks, with an optional extension up to 26 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Insulin Resistance Respiratory Aspiration type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

Barbara Davis Center for Diabetes Young Adult Clinic
RECRUITING

Aurora, Colorado, 80045, United States
Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Children's Hospital Los Angeles
RECRUITING

Los Angeles, California, 90027, United States
Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States
Joslin Diabetes Center
RECRUITING

Boston, Massachusetts, 02215, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94158, United States
University of Florida
RECRUITING

Gainsville, Florida, 32610, United States
University of Oklahoma Health Sciences Center
RECRUITING

Oklahoma City, Oklahoma, 73104, United States
University of Virginia
RECRUITING

Charlottesville, Virginia, 22903, United States
Yale University
RECRUITING

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.